Sales Down Thanks to Actos Bladder Cancer Publicity

Monday, 29 October 2012 08:00

 

 

Sales Down Thanks to Actos Bladder Cancer Publicity

By John Curran

 

As new drugs come into the market, pharmaceutical companies struggle to gain a foothold. Takeda Pharmaceuticals is facing this over its current diabetes drug Acots, as well as the generic version of its Type 2 diabetes treatment drug coming onto the market. However, the company may try to find other revenue streams. Actos (pioglitazone) bladder cancer risks are already driving sales down

It has had an FDA "black box" warning listed on the prescription for five years now. Actos bladder cancer risks dominate the warning, but pioglitazone congestive heart failure risks are also notable. In woman, it is more likely to cause Actos bone fracture conditions, forcing them to consider increased calcium through supplements or other options. These warnings are turning patients off to the medication.

While there are other drugs that can reduce blood sugar on the market, the FDA has ignored the frequent filing of cases by Actos bladder cancer class action lawsuit attorneys. This comes in contrast to France, which like other European Union countries has shown a willingness to ban unsafe medications with nasty side effects. The FDA finally noted last year that Actos bladder cancer risks are much higher than average, up to two or three times more common.

When one considers this, along with pioglitazone congestive heart failure risks, it becomes unclear why patients would not be extra cautious. Those who also have a medical history or genetic background for osteoporosis are in the same boat. Thanks to the prevalence of Type 2 diabetes in the U.S. population, there will continue to be a number of options available to Americans, many of which are safer.

If you or someone you know has developed dangerous conditions while on this medication, you may be able to get legal help. Visit the Actos Bladder Cancer Class Action Lawsuit Investigation and fill out the short form there. You'll receive a free legal review of your case by a pioglitazone congestive heart failure lawsuit lawyer. Pursuing a legal claim may help pay for loss of quality life and expensive medical bills. It costs you nothing, so get started today with one of our pioglitazone congestive heart failure lawsuit lawyer.

Updated October 29th, 2012

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

Last Updated on Thursday, 27 December 2012 11:09